DrugPatentWatch Database Preview
UROVIST MEGLUMINE DIU/CT Drug Profile
When do Urovist Meglumine Diu/ct patents expire, and what generic alternatives are available?
The generic ingredient in UROVIST MEGLUMINE DIU/CT is diatrizoate meglumine. There are nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the diatrizoate meglumine profile page.
Summary for UROVIST MEGLUMINE DIU/CT
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Bulk Api Vendors: | 12 |
| Clinical Trials: | 33 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | see details |
| DailyMed Link: | UROVIST MEGLUMINE DIU/CT at DailyMed |
Medical Subject Heading (MeSH) Categories for UROVIST MEGLUMINE DIU/CT
US Patents and Regulatory Information for UROVIST MEGLUMINE DIU/CT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayer Hlthcare | UROVIST MEGLUMINE DIU/CT | diatrizoate meglumine | INJECTABLE;INJECTION | 087739-001 | Sep 23, 1982 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
